NextCure (NASDAQ:NXTC – Get Free Report) and NGM Biopharmaceuticals (NASDAQ:NGM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings. Insider & Institutional Ownership 47.8% of NextCure shares […]